[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ThePharmaLetter](/creator/twitter/ThePharmaLetter)
### Social Influence [#](/creator/twitter::71542880/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [countries](/list/countries)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[superior](/topic/superior) 2.38%, [acquisition](/topic/acquisition) 2.38%, [surge](/topic/surge) 2.38%, [$226m](/topic/$226m) 2.38%, [gilead sciences](/topic/gilead-sciences) 2.38%, [novartis](/topic/novartis) 2.38%, [$70b](/topic/$70b) XXXX%

**Top accounts mentioned or mentioned by**
[@novonordisk](/creator/undefined) [@sanofis](/creator/undefined) [@pharmaessentia](/creator/undefined) [@novonordisks](/creator/undefined) [@celltrioninc](/creator/undefined) [@gileadsciences](/creator/undefined) [@aspirepharmas](/creator/undefined) [@hikmapharma](/creator/undefined) [@akerotx](/creator/undefined) [@cencoraglobal](/creator/undefined) [@natcopharmaltd](/creator/undefined) [@regeneron](/creator/undefined) [@arcusbio](/creator/undefined) [@kyowakirinus](/creator/undefined) [@pfizer](/creator/undefined) [@astellasus](/creator/undefined) [@omeroscorp](/creator/undefined) [@mercks](/creator/undefined) [@novartis](/creator/undefined) [@merck](/creator/undefined)

**Top assets mentioned**
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Novartis AG (NVS)](/topic/novartis)